- On December 2023, AstraZeneca revealed plans for a potential collaboration with the world's leading pharmaceutical company to focus on harnessing generative AI technology. This partnership aims to accelerate the discovery of new cancer treatments. By leveraging advanced AI capabilities, they seek to enhance the efficiency and effectiveness of the drug development process
- On July 2023, Biocon announced the successful integration of its Viatris biosimilars business across more than 70 countries in emerging markets. This strategic move has significantly expanded the company's operational reach and capabilities. The integration enhances Biocon's presence in the biosimilars sector, allowing for greater access to affordable treatments in diverse regions
- In June 2023, Aurobindo Pharma announced that its wholly owned subsidiary, Eugia Pharma Specialities Ltd., has entered into a voluntary sub-licensing agreement with the Medicines Patent Pool (MPP). This agreement focuses on the development and commercialization of a novel anti-cancer medication. The partnership aims to enhance access to essential cancer treatments, reflecting Aurobindo's commitment to addressing global health challenges
Frequently Asked Questions
The market is segmented based on Segmentation, By Type (Synthetic Statins and Natural Statins), Drug Class (Atorvastatin, Fluvastatin, Lovastatin, Rosuvastatin, Simvastatin, and Pitavastatin), Therapeutic Area (Cardiovascular Disorders, Obesity, Inflammatory Disorders, and Others), Application (Cardiovascular Diseases, Lifestyle Diseases, and Others), End User (Hospitals, Clinics, and Others) – Industry Trends and Forecast to 2031
.
The Global Statin Market size was valued at USD 16.10 USD Billion in 2023.
The Global Statin Market is projected to grow at a CAGR of 4.7% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
